Clinical Trials Logo

Filter by:
NCT ID: NCT06054152 Active, not recruiting - Clinical trials for Non-small Cell Lung Cancer

CX3CR1+T Cell Predict Immunotherapy Efficacy

Start date: April 10, 2023
Phase:
Study type: Observational

This study aimed to evaluate the correlation between the proportion of flow-sorted CX3CR1+T cells in peripheral blood and the CX3CR1+T-specific gene signature and the efficacy of immunotherapy.

NCT ID: NCT06054126 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

COronary CoLLateralization in Type 2 diabEtic Patients With Chronic Total Occlusion

COLLECT
Start date: January 1, 2010
Phase:
Study type: Observational

A severe coronary artery obstruction is a prerequisite for spontaneous collateral recruitment. The formation of coronary collateral circulation(CCC) is significantly impaired in type 2 diabetic patients with chronic total occlusion (CTO) compared with non-diabetic patients with CTO. This retrospective cohort enrolls consecutive T2DM patients who had at least one lesion with coronary angiographic total occlusion.

NCT ID: NCT06054087 Not yet recruiting - Clinical trials for Diabetic Peripheral Neuropathic Pain

Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy

Start date: October 2023
Phase: N/A
Study type: Interventional

Diabetic Peripheral Neuropathy (DPN) is one of the most common chronic complications of diabetes mellitus, which mainly manifests symmetric pain, numbness, ankylosis, or with abdominal distension, abnormal sweating, and accompanied by glove-sock-like hyperalgesia or loss of sensation as the main symptom, which seriously affects the quality of life of patients. Although drug treatment has some effect, from the overall long-term perspective, long-term medication is easy to produce drug dependence, and often easy to cause ataxia, blurred vision, constipation, diplopia, nausea and other adverse drug reactions. Electroacupuncture treatment for DPN has certain advantages, with clear efficacy and no toxic side effects, and is being increasingly recognised by the public and professionals. The study is designed to observe the therapeutic effect and safety of electroacupuncture (EA) in the treatment of DPN.

NCT ID: NCT06053944 Recruiting - Clinical trials for Left Main Coronary Artery Disease

Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Left Main Coronary Artery Stenosis

FUNCTION II
Start date: October 18, 2023
Phase:
Study type: Observational [Patient Registry]

This is a prospective, observational, single-center study. The main purpose of this study is to evaluate the diagnostic accuracy of offline computational ultrasonic flow ratio (UFR) in predicting functionally significant left main (LM) coronary stenosis with conventional pressure wire-based fractional flow reserve (FFR) as the standard reference. The study will be conducted in Fuwai Hospital, and a total of 120 patients with intermediated left main coronary vessel diameter stenosis ≥30% and ≤80% are planned to be recruited. Participants who meet the inclusion criteria and do not meet the exclusion criteria will undergo intravascular ultrasound (IVUS) followed by FFR examination. IVUS imaging will be sent to an independent core laboratory for UFR calculation. UFR analyses were performed offline in a blinded fashion without awareness of FFR measurement. Using FFR≤0.80 as the gold standard, the sensitivity and specificity of UFR in the functional significance of left main coronary artery stenosis will be analyzed.

NCT ID: NCT06053801 Recruiting - Clinical trials for Chronic Spontaneous Urticaria

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Start date: February 16, 2024
Phase:
Study type: Observational

This non-interventional, multi-center, prospective post-approval study aims to provide safety and effectiveness data of Xolair® in Chinese adolescents with Chronic Spontaneous Urticaria who remain symptomatic despite H1 antihistamine treatment. The study period is 16 weeks which contains a 12-week treatment period and 4-week safety follow-up.

NCT ID: NCT06053112 Recruiting - Healthy Infants Clinical Trials

The Trial of a New Infant Formula in Healthy Term Chinese Infants

HexaHMO
Start date: November 12, 2023
Phase: N/A
Study type: Interventional

The aim of this randomized, controlled, multi-center, double-blind study of healthy term infants is to test the safety and efficacy of a new infant formula with a specific blend of six human milk oligosaccharides. The primary objective of the trial is to demonstrate the safety of the new infant formula supplemented by comparing the growth of infants randomized to the experimental formula versus the control formula from enrollment to the age of 4 months.

NCT ID: NCT06053021 Recruiting - Clinical trials for Acute Ischemic Stroke

Antiplatelet Therapy for AIS Patients With Thrombocytopenia

PERSIST
Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the safety and effectiveness of antiplatelet therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Participants will be prescribed antiplatelet agents and followed up for 3 months.

NCT ID: NCT06052813 Recruiting - AML, Adult Clinical Trials

A Study of BN104 in the Treatment of Acute Leukemia

Start date: September 16, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The Phase I/II trial is to learn the safety, pharmacokinetics, and preliminary efficacy of BN104 taken once daily or twice daily in patients with acute lymphocytic leukemia or acute myeloblastic leukemia.

NCT ID: NCT06052579 Completed - Spondylolisthesis Clinical Trials

Comparison Of A Novel Hand-held Retractor-Assisted Transforaminal Lumbar Interbody Fusion By The Wiltse Approach And Posterior TLIF

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

In recent years, hand-held retractors have been applied to assist in Wiltse approach to perform canal decompression, causing less paraspinal muscle injury and yielding better postoperative clinical outcomes than P-TLIF. However, few prospective studies have been conducted comparing the clinical and radiological outcomes between Wiltse TLIF and P-TLIF, both assisted by hand-held retractors. Therefore, further research is warranted to assess whether hand-held retractor-assisted Wiltse TLIF can yield less paraspinal muscle injury and better postoperative clinical outcomes.

NCT ID: NCT06052527 Completed - COVID-19 Clinical Trials

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

Start date: June 16, 2023
Phase:
Study type: Observational [Patient Registry]

This is an open-tabled, one-arm observatory trial to assess the effectiveness and safety of the Autonomous Treatment System Based on Machine Learning in patients with Covid-19, Post-Acute Sequelae of SARS-CoV-2 infection and influenza.